We investigated the potential of sNfL Z-score, NfL ratio, NfL index, and Qalb as biomarkers of clinical outcome and for the classification of subtypes in a large cohort of GBS patients. The gene discussed is NEFL; the disease is Guillain-Barre syndrome.